273 related articles for article (PubMed ID: 8498881)
41. Estradiol in premenstrual asthma: a double-blind, randomized, placebo-controlled, crossover study.
Ensom MH; Chong G; Zhou D; Beaudin B; Shalansky S; Bai TR
Pharmacotherapy; 2003 May; 23(5):561-71. PubMed ID: 12741429
[TBL] [Abstract][Full Text] [Related]
42. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Fawcett J; Edwards JH; Kravitz HM; Jeffriess H
J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
[TBL] [Abstract][Full Text] [Related]
43. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
Freeman EW; Rickels K; Sondheimer SJ
J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
[TBL] [Abstract][Full Text] [Related]
44. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
Sundblad C; Modigh K; Andersch B; Eriksson E
Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
[TBL] [Abstract][Full Text] [Related]
45. The effects of vitamin B1 on ameliorating the premenstrual syndrome symptoms.
Abdollahifard S; Rahmanian Koshkaki A; Moazamiyanfar R
Glob J Health Sci; 2014 Jul; 6(6):144-53. PubMed ID: 25363099
[TBL] [Abstract][Full Text] [Related]
46. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial.
Fanaei H; Khayat S; Kasaeian A; Javadimehr M
Neuropeptides; 2016 Apr; 56():25-31. PubMed ID: 26608718
[TBL] [Abstract][Full Text] [Related]
47. The significance of "nonsignificance" in randomized controlled studies: a discussion inspired by a double-blinded study on St. John's wort (Hypericum perforatum L.) for premenstrual symptoms.
Hicks SM; Walker AF; Gallagher J; Middleton RW; Wright J
J Altern Complement Med; 2004 Dec; 10(6):925-32. PubMed ID: 15673985
[TBL] [Abstract][Full Text] [Related]
48. Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
Wikander I; Sundblad C; Andersch B; Dagnell I; Zylberstein D; Bengtsson F; Eriksson E
J Clin Psychopharmacol; 1998 Oct; 18(5):390-8. PubMed ID: 9790157
[TBL] [Abstract][Full Text] [Related]
49. Problems in the treatment of premenstrual syndrome.
Robinson GE; Garfinkel PE
Can J Psychiatry; 1990 Apr; 35(3):199-206. PubMed ID: 2187582
[TBL] [Abstract][Full Text] [Related]
50. Chromium supplementation for menstrual cycle-related mood symptoms.
Brownley KA; Girdler SS; Stout AL; McLeod MN
J Diet Suppl; 2013 Dec; 10(4):345-56. PubMed ID: 24237190
[TBL] [Abstract][Full Text] [Related]
51. Alprazolam and amitriptyline in the treatment of moderate depression.
Lapierre YD; Browne M; Oyewumi K; Sarantidis D
Int Clin Psychopharmacol; 1994; 9(1):41-5. PubMed ID: 8195582
[TBL] [Abstract][Full Text] [Related]
52. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study.
De Souza MC; Walker AF; Robinson PA; Bolland K
J Womens Health Gend Based Med; 2000 Mar; 9(2):131-9. PubMed ID: 10746516
[TBL] [Abstract][Full Text] [Related]
53. Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder.
Evans SM; Foltin RW; Fischman MW
Appetite; 1999 Jun; 32(3):331-49. PubMed ID: 10336792
[TBL] [Abstract][Full Text] [Related]
54. Symptoms of premenstrual syndrome and their association with migraine headache.
Martin VT; Wernke S; Mandell K; Ramadan N; Kao L; Bean J; Liu J; Zoma W; Rebar R
Headache; 2006 Jan; 46(1):125-37. PubMed ID: 16412160
[TBL] [Abstract][Full Text] [Related]
55. Fluoxetine's spectrum of action in premenstrual syndrome.
Menkes DB; Taghavi E; Mason PA; Howard RC
Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
[TBL] [Abstract][Full Text] [Related]
56. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
57. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.
Sundblad C; Hedberg MA; Eriksson E
Neuropsychopharmacology; 1993 Sep; 9(2):133-45. PubMed ID: 8216696
[TBL] [Abstract][Full Text] [Related]
58. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
O'Brien PM; Abukhalil IE
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
[TBL] [Abstract][Full Text] [Related]
59. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of Echium amoenum on premenstrual syndrome: a randomized, double-blind, controlled trial.
Farahmand M; Khalili D; Ramezani Tehrani F; Amin G; Negarandeh R
BMC Complement Med Ther; 2020 Sep; 20(1):295. PubMed ID: 32993653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
